The U.S. organ-on-a-chip (OoC) market, valued at USD 74.25 million in 2024, is anticipated to register a compound annual growth rate (CAGR) of 33.0% from 2025 to 2034, driven by the urgent need to replace animal testing, accelerate drug development timelines, and improve the predictive accuracy of preclinical models. Organ-on-a-chip technology—microfluidic cell culture devices that...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek